SCHEMBL13153271

SCHEMBL13153271

CCn1c(-c2ccc(NS(=O)(=O)CCCCl)cc2)c(N)c2ccc(OC)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK2 Q13002 3/20 0.40
GRIK1 P39086 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
HSD17B10 Q99714 1/20 0.39
SGK1 O00141 2/20 0.39
DYRK1A Q13627 5/20 0.39
AR P10275 1/20 0.36
KIT P10721 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.34
PLK4 O00444 1/20 0.34
DCLK1 O15075 1/20 0.34
DAPK3 O43293 1/20 0.34
DYRK3 O43781 1/20 0.34
JAK2 O60674 1/20 0.34
ROCK2 O75116 1/20 0.34
PRKD3 O94806 1/20 0.34
MAP4K4 O95819 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13152144 0.93 DYRK1A (0.40) KDM4EALDH1A1HSD17B10SGK1DYRK1A
SCHEMBL13152602 0.92 DYRK1A (0.43) KDM4EALDH1A1HSD17B10SGK1DYRK1A
SCHEMBL13152229 0.90 GRIK2 (0.43) GRIK2GRIK1KDM4EALDH1A1MAPK1
SCHEMBL13152362 0.90 GRIK2 (0.43) GRIK2GRIK1KDM4EALDH1A1MAPK1
SCHEMBL13152664 0.90 SGK1 (0.37) GRIK2GRIK1KDM4EALDH1A1MAPK1
SCHEMBL13152731 0.90 ALOX15 (0.36) KDM4EALDH1A1MAPK1SGK1DYRK1A
SCHEMBL10253098 0.90 ALDH1A1 (0.39) GRIK2GRIK1KDM4EALDH1A1MAPK1
SCHEMBL10249433 0.89 SGK1 (0.36) GRIK2GRIK1SGK1DYRK1AAR
SCHEMBL13152033 0.89 GRIK2 (0.46) GRIK2GRIK1KDM4EALDH1A1MAPK1
SCHEMBL13151781 0.87 KIT (0.40) GRIK2GRIK1KDM4EALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010118009-A1 HCV INHIBITOR AND THERAPEUTIC AGENT COMBINATIONS PTC THERAPEUTICS, INC. (US) 2010-10-14 WO disclosed